Optimizing provision of extracorporeal life support during the COVID-19 pandemic: practical considerations for Canadian jurisdictions
Open Access
- 6 April 2020
- journal article
- editorial
- Published by CMA Impact Inc. in CMAJ : Canadian Medical Association Journal
- Vol. 192 (14), E372-E374
- https://doi.org/10.1503/cmaj.200448
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Critical Care Utilization for the COVID-19 Outbreak in Lombardy, ItalyJAMA, 2020
- Care for Critically Ill Patients With COVID-19JAMA, 2020
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019New England Journal of Medicine, 2020
- Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirusAnnals of Intensive Care, 2018
- What’s new in ECMO: scoring the bad indicationsIntensive Care Medicine, 2014
- Extracorporeal Membrane Oxygenation for Pandemic Influenza A(H1N1)–induced Acute Respiratory Distress SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Adapting the Hamilton Health Sciences Critical Care Pandemic Triage ProtocolWorld Health & Population, 2010
- Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress SyndromeJAMA, 2009
- Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trialThe Lancet, 2009